BRCA1 and breast cancer: Unsupervised hierarchical clustering of all 350 CpGs revealed a distinct “BRCA1-like cluster”, implying the potential utility of genome-scale DNA methylation as another biomarker to identify HR-deficient cancers, possibly in breast cancer biopsies shown to have similar methylation profiles to larger surgical blocks [55].